Alembic Pharma commissions new manufacturing facility in Pithampur to expand business

The new plant, which represents an investment of approximately Rs 205 crore, has been financed through internal accruals/borrowings.

According to the company, the rationale behind establishing the facility is to expand its business and provide an opportunity to move third-party products in-house.

Read also: Alembic Pharma appoints Prag Goel as Vice President - Sales and Marketing (Megacare, Enteron and Osteofit business divisions)

Alembic already operates multiple manufacturing facilities for formulations, most of which are currently operating at optimal utilization levels.

Last month, Alembic Global Holding SA, a wholly owned subsidiary of the company, incorporated a wholly-owned subsidiary in USA, named Alembic Lifesciences Inc.

Read also: Alembic Global Holding incorporates wholly-owned subsidiary in USA

Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA.